Related Experiment Videos
1995-1996 influenza season: Canadian laboratory diagnoses and strain characterization
1National Laboratory for Special Pathogens, Bureau of Microbiology, LCDC, Ottawa, Ontario.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
alpha-Aspartate 261 is a key residue in noncatalytic sites of Escherichia coli F1-ATPase.
The Journal of biological chemistry·1995
P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site.
The Journal of biological chemistry·1995
Effects of the German 1993 health reform law upon primary care practitioners' individual performance: results from an empirical study in sentinel practices.
Journal of epidemiology and community health·1995
Gene-based sequence-tagged-sites (STSs) as the basis for a human gene map.
Nature genetics·1995
HIV positive patients first presenting with an AIDS defining illness: characteristics and survival.
BMJ (Clinical research ed.)·1995
Increase of skeletal muscle relaxation speed by direct injection of parvalbumin cDNA.
Proceedings of the National Academy of Sciences of the United States of America·1995
Characteristics of outpatient nirmatrelvir/ritonavir recipients during the 2022/2023 era in Alberta, Canada: A retrospective observational population-based study.
Canada communicable disease report = Releve des maladies transmissibles au Canada·2026
Mycobacterium abscessus soft tissue infections associated with subcutaneous injection of lipolytic agents: An outbreak report and novel molecular epidemiology analysis approach.
Canada communicable disease report = Releve des maladies transmissibles au Canada·2026
Economic evaluation of wastewater surveillance in Ontario, Canada, using COVID-19 as a case study.
Canada communicable disease report = Releve des maladies transmissibles au Canada·2026
Intraseasonal waning of influenza vaccine effectiveness and implications for the optimal timing of seasonal vaccination programs: A scoping review.
Canada communicable disease report = Releve des maladies transmissibles au Canada·2026
Summary of the National Advisory Committee on Immunization (NACI) Statement: Updated guidance on respiratory syncytial virus (RSV) vaccines for older adults and for adults at high risk of severe RSV disease.
Canada communicable disease report = Releve des maladies transmissibles au Canada·2026
Summary of the National Advisory Committee on Immunization (NACI) Statement: Updated guidance to protect infants and children from respiratory syncytial virus disease.
Canada communicable disease report = Releve des maladies transmissibles au Canada·2026
Updated total calcium reference intervals for Abbott Alinity c using Calcium2 reagents.
Clinical biochemistry·2026
Evaluation of a new non-competitive chemiluminescent immunoassay for 25-OH vitamin D measurement.
Diagnosis (Berlin, Germany)·2026
Development and Validation of an LC-MS/MS-Based Screening Method for Determination of Salbutamol in Urine for Doping Control Using a Surrogate Analyte Approach with Stable Isotope-Labeled Salbutamol (Salbutamol-d9).
Iranian journal of pharmaceutical research : IJPR·2026